Key facts
- This page summarizes Alison Bauerlein's Form 4 filing for Pear Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Feb 2023, 15:09.
Alison Bauerlein - 15 Feb 2023 Form 4 Insider Report for Pear Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 15 Feb 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Feb 2023, 15:09:25 UTC
- Prior SEC filing
- 16 Jun 2022
- Next SEC filing
- 05 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stacie S. Aarestad, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alison Bauerlein filed Form 4 for Pear Therapeutics, Inc. on 17 Feb 2023.
Change
- Previous filing in this sequence was filed on 16 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PEARQ
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +71,428
- Change %
- Price
- $0.000000
- Shares after
- 71,428
- Date
- 15 Feb 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.